Press Releases Archives - Page 36 of 103 - Lupin

BSE 2277.90 NSE 2273.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2277.90 NSE 2273.90

Lupin Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets

October 6, 2021

Lupin Launches Droxidopa Capsules in the United States

September 28, 2021

Lupin Launches Authorized Generic Version of Duexis® in the United States

September 15, 2021

TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB

September 6, 2021

Lupin Launches Luforbec® for treatment of Asthma & COPD, in the UK

August 24, 2021

Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets

August 16, 2021

Lupin Quarter I FY2022 Results

August 10, 2021

Lupin Acquires Southern Cross Pharma in Australia

Lupin Launches Tavaborole Topical Solution in the United States

Lupin Announces FDA Approval of Supplemental New Drug Application for SOLOSEC® (secnidazole) for the Treatment of Trichomoniasis

1 2 … 35 36 37 … 102 103

Search

Hit enter to search or ESC to close